Northern Trust Corp Viking Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $572 Billion
  • Q1 2024

A detailed history of Northern Trust Corp transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 952,857 shares of VKTX stock, worth $50.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
952,857
Previous 916,380 3.98%
Holding current value
$50.5 Million
Previous $17.1 Million 358.18%
% of portfolio
0.01%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.4 - $94.5 $634,699 - $3.45 Million
36,477 Added 3.98%
952,857 $78.1 Million
Q4 2023

Feb 13, 2024
SELL
$9.24 - $19.64 $103,321 - $219,614
-11,182 Reduced 1.21%
916,380 $17.1 Million
Q3 2023

Nov 13, 2023
BUY
$10.92 - $16.0 $173,344 - $253,984
15,874 Added 1.74%
927,562 $10.3 Million
Q2 2023

Aug 11, 2023
BUY
$14.84 - $24.79 $11 Million - $18.3 Million
739,868 Added 430.61%
911,688 $14.8 Million
Q1 2023

May 15, 2023
BUY
$8.08 - $17.33 $363,907 - $780,508
45,038 Added 35.52%
171,820 $2.86 Million
Q4 2022

Feb 13, 2023
SELL
$2.72 - $9.4 $38 - $131
-14 Reduced 0.01%
126,782 $1.19 Million
Q2 2022

Aug 12, 2022
SELL
$2.11 - $3.15 $1.1 Million - $1.64 Million
-522,075 Reduced 80.46%
126,796 $366,000
Q1 2022

May 13, 2022
SELL
$3.0 - $4.88 $626,709 - $1.02 Million
-208,903 Reduced 24.35%
648,871 $1.95 Million
Q4 2021

Feb 08, 2022
SELL
$4.6 - $6.72 $532,371 - $777,725
-115,733 Reduced 11.89%
857,774 $3.95 Million
Q3 2021

Nov 15, 2021
SELL
$5.58 - $7.04 $146,720 - $185,109
-26,294 Reduced 2.63%
973,507 $6.11 Million
Q2 2021

Aug 13, 2021
SELL
$5.19 - $6.73 $5,413 - $7,019
-1,043 Reduced 0.1%
999,801 $5.99 Million
Q1 2021

May 12, 2021
SELL
$5.74 - $9.67 $2.01 Million - $3.38 Million
-349,322 Reduced 25.87%
1,000,844 $6.33 Million
Q4 2020

Feb 11, 2021
SELL
$5.3 - $6.71 $198,108 - $250,813
-37,379 Reduced 2.69%
1,350,166 $7.6 Million
Q3 2020

Nov 16, 2020
SELL
$5.73 - $8.11 $214,433 - $303,500
-37,423 Reduced 2.63%
1,387,545 $8.08 Million
Q2 2020

Aug 14, 2020
BUY
$4.35 - $8.08 $2.72 Million - $5.05 Million
624,386 Added 77.99%
1,424,968 $10.3 Million
Q1 2020

May 14, 2020
SELL
$3.45 - $7.95 $57,970 - $133,583
-16,803 Reduced 2.06%
800,582 $3.75 Million
Q4 2019

Feb 14, 2020
SELL
$6.38 - $8.73 $74,748 - $102,280
-11,716 Reduced 1.41%
817,385 $6.56 Million
Q3 2019

Nov 13, 2019
BUY
$6.55 - $8.6 $394,539 - $518,021
60,235 Added 7.83%
829,101 $5.7 Million
Q2 2019

Aug 13, 2019
BUY
$7.67 - $10.63 $91,395 - $126,667
11,916 Added 1.57%
768,866 $6.38 Million
Q1 2019

May 13, 2019
BUY
$7.58 - $9.94 $212,179 - $278,240
27,992 Added 3.84%
756,950 $7.52 Million
Q4 2018

Feb 12, 2019
BUY
$7.16 - $16.21 $816,204 - $1.85 Million
113,995 Added 18.54%
728,958 $5.58 Million
Q3 2018

Nov 14, 2018
BUY
$9.7 - $19.65 $1.18 Million - $2.4 Million
122,118 Added 24.78%
614,963 $10.7 Million
Q2 2018

Sep 18, 2018
BUY
$3.88 - $12.74 $87,517 - $287,363
22,556 Added 4.8%
492,845 $4.68 Million
Q2 2018

Aug 14, 2018
BUY
$3.88 - $12.74 $1.52 Million - $4.99 Million
391,336 Added 495.66%
470,289 $4.46 Million
Q1 2018

May 09, 2018
BUY
$4.11 - $6.93 $159,883 - $269,583
38,901 Added 97.13%
78,953 $345,000
Q4 2017

Feb 14, 2018
BUY
$1.74 - $4.34 $40,176 - $100,210
23,090 Added 136.13%
40,052 $163,000
Q3 2017

Nov 13, 2017
BUY
$0.94 - $1.91 $15,944 - $32,397
16,962
16,962 $32,000

Others Institutions Holding VKTX

# of Institutions
426
Shares Held
63.1M
Call Options Held
7.39M
Put Options Held
5.13M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.07B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email